Details of the Drug

General Information of Drug (ID: DMZUA5C)

Drug Name
MK-6302
Synonyms INS-20; Pegylated GCSF, Insmed/Merck
Indication
Disease Entry ICD 11 Status REF
Neutropenia 4B00.0 Phase 1 [1]
Cross-matching ID
TTD ID
D08YGY

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Granulocyte colony-stimulating factor receptor (G-CSF-R) TTC70AJ CSF3R_HUMAN Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Neutropenia
ICD Disease Classification 4B00.0
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Granulocyte colony-stimulating factor receptor (G-CSF-R) DTT CSF3R 2.08E-08 0.36 0.96
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of Merck.
2 Merck ditches biogeneric. Nat Biotechnol. 2010 Jul;28(7):636.